Cargando…

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients

INTRODUCTION: Isolated disseminated tumour cells (DTC) are regarded as surrogate markers for minimal residual disease in breast cancer. Characterisation of these cells could help understand the known limitations of adjuvant therapy. Of particular interest is their oestrogen-receptor (ER) status beca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fehm, Tanja, Krawczyk, Natalia, Solomayer, Erich-Franz, Becker-Pergola, Graziella, Dürr-Störzer, Silke, Neubauer, Hans, Seeger, Harald, Staebler, Annette, Wallwiener, Diethelm, Becker, Sven
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614509/ https://www.ncbi.nlm.nih.gov/pubmed/18793387 http://dx.doi.org/10.1186/bcr2143

Ejemplares similares

Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer
por: Fehm, Tanja, et al.
Publicado: (2006)

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
por: Fehm, Tanja, et al.
Publicado: (2009)

Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
por: Banys, Malgorzata, et al.
Publicado: (2013)

Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay
por: Fehm, Tanja, et al.
Publicado: (2012)

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
por: Fehm, Tanja, et al.
Publicado: (2007)

The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy
por: Hartkopf, Andreas Daniel, et al.
Publicado: (2013)

Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients
por: Krawczyk, Natalia, et al.
Publicado: (2014)

Circulating and Disseminated Tumor Cells in Breast Carcinoma: Report from the Consensus Conference on Tumor Cell Dissemination during the 39th Annual Meeting of the German Society of Senology, Berlin, 27 June 2019
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Circulating and Disseminated Tumour Cells in Breast Carcinoma: Report from the Consensus Conference on Tumour Cell Dissemination during the 38th Annual Meeting of the German Society of Senology, Berlin, 14 June 2018
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments
por: Honig, Arnd, et al.
Publicado: (2005)

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
por: Lengerke, Claudia, et al.
Publicado: (2011)

The Role and Clinical Relevance of Disseminated Tumor Cells in Breast Cancer
por: Banys, Malgorzata, et al.
Publicado: (2014)

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2012)

Evidence of ERalpha and ERbeta selectivity and partial estrogen agonism in traditional Chinese medicine
por: Tiosano, Dov, et al.
Publicado: (2014)

Comment on the LACC Trial Investigating Early-stage Cervical Cancer by the Uterus Commission of the Study Group for Gynecologic Oncology (AGO) and the Study Group for Gynecologic Endoscopy (AGE) of the German Society for Gynecology and Obstetrics (DGGG)
por: Hillemanns, Peter, et al.
Publicado: (2018)

Regulation of semaphorin 4D expression and cell proliferation of ovarian cancer by ERalpha and ERbeta
por: Liu, Y., et al.
Publicado: (2017)

Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression
por: Thiebaut, Charlène, et al.
Publicado: (2017)

Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients
por: Hartkopf, Andreas D., et al.
Publicado: (2016)

An Alkylphenol Mix Promotes Seminoma Derived Cell Proliferation through an ERalpha36-Mediated Mechanism
por: Ajj, Hussein, et al.
Publicado: (2013)

SUN-469 Hypothalamic ERalpha Gene Silencing Diminishes Sexual Receptivity in Female Marmoset Monkeys
por: Kraynak, Marissa, et al.
Publicado: (2019)

Selective microdochectomy after ductoscopic wire marking in women with pathological nipple discharge
por: Hahn, M, et al.
Publicado: (2009)

Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer
por: Gruber, Ines V, et al.
Publicado: (2013)

Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha
por: Frietze, Seth, et al.
Publicado: (2014)

Investigating the effect of visfatin on ERalpha phosphorylation (Ser118 and Ser167) and ERE-dependent transcriptional activity
por: Zangooei, Mohammad, et al.
Publicado: (2018)

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2016)

High-throughput cell-based screening reveals a role for ZNF131 as a repressor of ERalpha signaling
por: Han, Xiao, et al.
Publicado: (2008)

Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers
por: Schultz, Silke, et al.
Publicado: (2018)

Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
por: Neubauer, Hans, et al.
Publicado: (2008)

Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
por: Neubauer, Hans, et al.
Publicado: (2009)

A bead-based western for high-throughput cellular signal transduction analyses
por: Treindl, Fridolin, et al.
Publicado: (2016)

The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer
por: Eichbaum, Michael, et al.
Publicado: (2011)

Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification
por: Wallwiener, Markus, et al.
Publicado: (2012)

Comparative Analysis of Blood and Bone Marrow for the Detection of Circulating and Disseminated Tumor Cells and Their Prognostic and Predictive Value in Esophageal Cancer Patients
por: Richter, Florian, et al.
Publicado: (2020)

Classifying breast cancer surgery: a novel, complexity-based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients
por: Hoffmann, Jürgen, et al.
Publicado: (2009)

Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?
por: Chebouti, Issam, et al.
Publicado: (2016)

Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
por: Krawczyk, Natalia, et al.
Publicado: (2014)

Gene Expression Profiling Reveals New Aspects of PIK3CA Mutation in ERalpha-Positive Breast Cancer: Major Implication of the Wnt Signaling Pathway
por: Cizkova, Magdalena, et al.
Publicado: (2010)

Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.
por: Solomayer, E. F., et al.
Publicado: (1997)

The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service
por: Wallwiener, Markus, et al.
Publicado: (2010)

Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jjgf8qv96f7je7rauacbc775rr